{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T03:15:11Z","timestamp":1740107711024,"version":"3.37.3"},"reference-count":8,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2023,10,12]],"date-time":"2023-10-12T00:00:00Z","timestamp":1697068800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,10,12]],"date-time":"2023-10-12T00:00:00Z","timestamp":1697068800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1007\/s10067-023-06791-6","type":"journal-article","created":{"date-parts":[[2023,10,12]],"date-time":"2023-10-12T03:28:52Z","timestamp":1697081332000},"page":"835-836","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Comment on \u201cSodium glucose cotransporter 2 inhibitors and gout risk\u201d"],"prefix":"10.1007","volume":"43","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7420-1572","authenticated-orcid":false,"given":"Shih-Wei","family":"Lai","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bing-Fang","family":"Hwang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chiu\u2011Shong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kuan-Fu","family":"Liao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,10,12]]},"reference":[{"key":"6791_CR1","doi-asserted-by":"publisher","first-page":"2469","DOI":"10.1007\/s10067-023-06647-z","volume":"42","author":"DT Wood","year":"2023","unstructured":"Wood DT, Waterbury NV, Lund BC (2023) Sodium glucose cotransporter 2 inhibitors and gout risk: a sequence symmetry analysis. Clin Rheumatol 42:2469\u20132475","journal-title":"Clin Rheumatol"},{"key":"6791_CR2","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2021.35353","volume":"4","author":"MC Chung","year":"2021","unstructured":"Chung MC, Hung PH, Hsiao PJ, Wu LY, Chang CH, Wu MJ et al (2021) Association of sodium-glucose transport protein 2 inhibitor use for type 2 diabetes and incidence of gout in Taiwan. JAMA Netw Open 4:e2135353","journal-title":"JAMA Netw Open"},{"key":"6791_CR3","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1097\/MNH.0000000000000632","volume":"29","author":"JA Dominguez Rieg","year":"2020","unstructured":"Dominguez Rieg JA, Xue J, Rieg T (2020) Tubular effects of sodium-glucose cotransporter 2 inhibitors: intended and unintended consequences. Curr Opin Nephrol Hypertens 29:523\u2013530","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"6791_CR4","doi-asserted-by":"publisher","first-page":"F173","DOI":"10.1152\/ajprenal.00462.2018","volume":"316","author":"A Novikov","year":"2019","unstructured":"Novikov A, Fu Y, Huang W, Freeman B, Patel R, van Ginkel C et al (2019) SGLT2 inhibition and renal urate excretion: role of luminal glucose, GLUT9, and URAT1. Am J Physiol Renal Physiol 316:F173\u2013F185","journal-title":"Am J Physiol Renal Physiol"},{"key":"6791_CR5","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1007\/s00592-022-01866-3","volume":"59","author":"M Banerjee","year":"2022","unstructured":"Banerjee M, Pal R, Mukhopadhyay S (2022) Can SGLT2 inhibitors prevent incident gout? A systematic review and meta-analysis. Acta Diabetol 59:783\u2013791","journal-title":"Acta Diabetol"},{"key":"6791_CR6","doi-asserted-by":"publisher","first-page":"1158153","DOI":"10.3389\/fendo.2023.1158153","volume":"14","author":"SW Lai","year":"2023","unstructured":"Lai SW, Hwang BF, Kuo YH, Liu CS, Liao KF (2023) Sodium-glucose cotransporter-2 inhibitors use and the risk of gout: a systematic review and meta-analysis. Front Endocrinol (Lausanne) 14:1158153","journal-title":"Front Endocrinol (Lausanne)"},{"key":"6791_CR7","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1016\/0895-4356(90)90131-8","volume":"43","author":"H Petri","year":"1990","unstructured":"Petri H, Leufkens H, Naus J, Silkens R, van Hessen P, Urquhart J (1990) Rapid method for estimating the risk of acutely controversial side effects of prescription drugs. J Clin Epidemiol 43:433\u2013439","journal-title":"J Clin Epidemiol"},{"key":"6791_CR8","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.1002\/pds.5252","volume":"30","author":"LC Lund","year":"2021","unstructured":"Lund LC, H\u00f8jlund M, Henriksen DP, Hallas J, Kristensen KB (2021) Sodium-glucose cotransporter-2 inhibitors and the risk of gout: a Danish population based cohort study and symmetry analysis. Pharmacoepidemiol Drug Saf 30:1391\u20131395","journal-title":"Pharmacoepidemiol Drug Saf"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-023-06791-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10067-023-06791-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-023-06791-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T11:11:24Z","timestamp":1706785884000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10067-023-06791-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,12]]},"references-count":8,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,2]]}},"alternative-id":["6791"],"URL":"https:\/\/doi.org\/10.1007\/s10067-023-06791-6","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"type":"print","value":"0770-3198"},{"type":"electronic","value":"1434-9949"}],"subject":[],"published":{"date-parts":[[2023,10,12]]},"assertion":[{"value":"2 October 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 October 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 October 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 October 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors disclose no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}